Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, which is used to prevent polyp formation in familial adenomatous polyposis (FAP) patients, a population at high risk for colorectal cancer development [13]. This evidence concerns the gene PTGS2 and colorectal cancer.